AMGEN at the American College of Cardiology's (ACC) Annual Meeting

ACC 2022

April 2–4, Washington DC, Hybrid

Amgen is proud to be part of the American College of Cardiology's Annual Scientific Session & Expo in 2022. While you are here, you can explore the latest scientific information and disease state education from Amgen, and learn about Amgen's long-term commitment to developing and delivering transformative medicines for patients with cardiovascular disease.

Amgen | A Worldwide Pioneer in Biotechnology

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing, and delivering innovative human therapeutics. A biotechnology pioneer since 1980, Amgen has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
For more information, visit and follow us on